Funders › NY › Marc Lustgarten Pancreatic Cancer Foundation › 2023
Grants paid by Marc Lustgarten Pancreatic Cancer Foundation, tax year 2023
EIN 31-1611837 · Uniondale, NY · Form 990, Schedule I · NTEE P112
In tax year 2023, Marc Lustgarten Pancreatic Cancer Foundation (EIN 31-1611837) reported 18 grants paid totaling $18,982,494. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Johns Hopkins University Baltimore, MD | A | $5,726,518 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Cold Spring Harbor Laboratory Cold Spring Harbor, NY | A | $2,472,272 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Dana Farber Cancer Institute Boston, MA | A | $2,161,911 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Massachusetts Institute of Technology Cambridge, MA | A | $1,575,933 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Stand Up Tp Cancer - Entertainment Industry Foundation Los Angeles, CA | A | $1,534,808 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | The Salk Institute for Biological Studies La Jolla, CA | A | $1,000,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | American Association for Cancer Research Philadelphia, PA | A | $990,664 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | The Regents of the University of California Los Angeles, CA | A | $773,195 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Nyu Grossman School of Medicine Boston, MA | A | $731,815 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Massachusettes General Hospital Boston, MA | A | $500,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Yale University New Haven, CT | A | $444,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | The Trustees of the University of Pennsylvania Philadelphia, PA | A | $400,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Duke University Durham, NC | A | $361,288 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Memorial Sloan Kettering Cancer Center New York, NY | A | $118,091 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Icahn School of Medicine at Mount Sinai New York, NY | A | $75,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | University of Texas Md Anderson Center Houston, TX | A | $74,999 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | The Trustees of Columbia University New York, NY | A | $27,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
| 2023 | Henry Ford Health System Detroit, MI | A | $15,000 | paid | PANCREATIC CANCER RESEARCH | 202430449349301853 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.